VertiSep™ BDS are highly base deactivation for basic compounds while offer superior efficiency for neutral and acidic compounds. VertiSep™ BDS has four stable reverse phase packings C18, C8, Phenyl and Cyano that well suited for pharmaceutical and other biological compounds
VertiSep™ BDS was developed to provide a physical and performance characteristics very similar to those of Hypersil® BDS.
VertiSep™ BDS provides the results indicated comparable capacity, selectivity efficiency and peak symmetry when compared to Hypersil® BDS. Most methods developed on Hypersil® BDS can be transfered to VertiSep™ BDS, even for USP applications.